Aytu BioScience Provides Quarterly Update on the Natesto(R) U.S. Launch

ENGLEWOOD, Colo., Oct. 26, 2017 -- (Healthcare Sales & Marketing Network) -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an update on... Biopharmaceuticals, Drug Delivery, Product Launch Aytu BioScience, Natesto, testosterone, low testosterone
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news